title: Sprue-like enteropathy linked to olmesartan.
abstract: Olmesartan is a therapy used for the management of hypertension available since 2002. A sprue like enteropathy associated with olmesartan has been first described in 2012. Endoscopic and histopathological findings are partial or total villous atrophy, mimicking a Celiac Disease. We explain two cases diagnosed in our hospital. Both patients took more than one year of treatment with olmesartan. In both cases, the biopsy showed duodenal villous atrophy, negative serology for celiac disease and they improved after stopping treatment with olmesartan. Olmesartan associate sprue-like enteropathy should be included in the differential diagnosis of seronegative villous atrophy. After the discontinuation of olmesartan, clinical remission usually occurs in every patients.
authors.affiliation: Aparato Digestivo, Hospital Universitario de Álava, España.
authors.forename: Amaia
authors.initials: A
authors.lastname: Campos Ruiz
authors.affiliation: Aparato Digestivo, Hospital Universitario de Álava.
authors.forename: Leire
authors.initials: L
authors.lastname: Urtasun Arlegui
authors.affiliation: Aparato Digestivo, Hospital Universitario de Álava.
authors.forename: Carlos
authors.initials: C
authors.lastname: Marra-López Valenciano
mesh_terms: D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D002446:Celiac Disease / Q000139:chemically induced* / Q000000981:diagnostic imaging; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D007093:Imidazoles; D013777:Tetrazoles; C437965:olmesartan